Advertisement

Topics

Eureka Genomics Corp. Company Profile

21:05 EST 10th December 2018 | BioPortfolio


News Articles [525 Associated News Articles listed on BioPortfolio]

Eureka Therapeutics announces Boehringer Ingelheim is exercising option to license novel TCRm) antibodies

Eureka Therapeutics announced that Boehringer Ingelheim has elected to exercise an option for the exclusive license of novel human TCR-mimicking (TCRm) antibodies against an undisclosed target to be u...

10X Genomics Prepares to Hire 200 New Employees, Move into Larger Facility

Bay Area-based genomics company 10X Genomics has become one of the fastest growing privately-held companies in the region with an earnings increase of more than 2,000 percent over a three-year period.

Boehringer Ingelheim Exercises an Option to License Novel TCR Mimic Antibodies from Eureka Therapeutics

EMERYVILLE, Calif.–(BUSINESS WIRE)–Eureka Therapeutics Inc. announced today that Boehringer Ingelheim has elected to exercise an option for the exclusive license of novel human TCR-mimicki...

Eureka Tx Announces Data Presentations Validating Its Proprietary E-ALPHA Discovery Platform #ASH18 https://www.businesswire.com/news/home/20181130005052/en/Eureka-Therapeutics-Announces-Data-Presentations-Validating-Proprietary …

Eureka Tx Announces Data Presentations Validating Its Proprietary E-ALPHA Discovery Platform #ASH18 https://www.businesswire.com/news/home/20181130005052/en/Eureka-Therapeutics-Announces-Data-Presen...

Microsoft Genomics Ventures into the Microbiome With Eagle Genomics

LONDON, October 15, 2018 /PRNewswire/ -- Cambridge technology innovators partner with Microsoft Genomics Microbiomic research into immune disorders and antibiotic resistance First microbiome partn...

One of the more interesting data today Eureka’s TCR-mimic CAR-T targeting intracellular/secreted alpha-fetoprotein (AFP) achieved a completed response in tough liver cancer in its PoC trial in China https://www.businesswire.com/news/home/2018090500526

One of the more interesting data today Eureka’s TCR-mimic CAR-T targeting intracellular/secreted alpha-fetoprotein (AFP) achieved a completed response in tough liver cancer in its PoC trial in ...

Eureka Therapeutics Announces Publication of Preclinical Study Validating its ARTEMIS Platform Designed to Mitigate the Risk of Cytokine Release Syndrome and Neurotoxicity

EMERYVILLE, Calif.–(BUSINESS WIRE)–Eureka Therapeutics, Inc., a clinical stage biopharmaceutical company with the goal of curing cancer by developing novel T-cell therapies that harness th...

Festival of Genomics London 2018: the landmark event making genomics mainstream

London, UK, 5th January 2018 / Sciad Newswire / This January sees the third edition of Festival of Genomics London, the largest meeting of its kind in the UK. Following two US editions of the event ...

PubMed Articles [208 Associated PubMed Articles listed on BioPortfolio]

Evaluation of fluorescence biomodulation in the real-life management of chronic wounds: the EUREKA trial.

Fluorescence biomodulation (FB), a form of photobiomodulation (PBM) that is also known as low energy level light (LELL), has become an increasingly used clinical tool to induce wound healing in wounds...

CORP: Partitional Calorimetry.

For thermal physiologists, calorimetry is an important methodological tool to assess human heat balance during heat or cold exposures. A whole-body direct calorimeter remains the gold standard instrum...

Utilization of Genomics and Functional Genomics to Inform Clinical Decisions in IR.

Single-cell genomics.

Current Social Media Conversations about Genetics and Genomics in Health: A Twitter-Based Analysis.

The growing availability of genomic information to the public may spur discussion about genetics and genomics on social media. Sites, including Twitter, provide a unique space for the public to access...

Clinical Trials [98 Associated Clinical Trials listed on BioPortfolio]

Electronic Medical Records and Genomics (eMERGE) Phase III

The Electronic Medical Records and Genomics (eMERGE) Network is in its third phase and during this time is enrolling and sequencing 25,000 individuals on a custom sequencing panel of clini...

Genomics and Postoperative Atrial Fibrillation

This research study is done to find out if genetic make up of a person plays a role in complications and recovery after the Coronary Artery Bypass Graft (CABG) operation. As you may be aw...

Home Outpatient Monitoring and Engagement to Predict HF Exacerbation

The HOME PREDICT HF study looks at new ways to predict hospitalizations for heart failure. We will use a set of devices at home and surveys to collect information about patient's health. T...

Microfluidics and Transcriptomics in Post Solid Organ Transplant Patients

The field of genomics is an exciting new field being applied in medicine. Its use in treating some cancers, sepsis and burn patients has been very promising. As knowledge of genomics and a...

High Throughput Drug Sensitivity and Genomics Data in Developing Individualized Treatment in Patients With Relapsed or Refractory Multiple Myeloma or Plasma Cell Leukemia

This pilot clinical trial studies whether using high throughput drug sensitivity and genomics data is feasible in developing individualized treatment in patients with multiple myeloma or p...

Companies [464 Associated Companies listed on BioPortfolio]

Eureka Genomics

Eureka Genomics is a privately held company and a leader in the advanced bioinformatics analysis of next-generation sequencing data. The company applies its capabilities to the di...

Eureka Genomics Corp.

Eureka Casino Resort

The Eureka Casino Resort is an intimate, newly renovated, 214-room resort located in Mesquite, Nevada, 35 miles south of St. George, Utah. The hotel recently renovated each guest room, and built a res...

Eureka Science

Eureka Science offers creative solutions to a large variety of publishing and related activities which may be purely online or of a more traditional hard copy variety. In addition, we also offer a w...

Eureka Therapeutics Inc.

Eureka Therapeutics Inc. is a privately held biotechnology company, headquartered in the San Francisco Bay area, focused on developing first-in-class T cell immunotherapies for he...

More Information about "Eureka Genomics Corp." on BioPortfolio

We have published hundreds of Eureka Genomics Corp. news stories on BioPortfolio along with dozens of Eureka Genomics Corp. Clinical Trials and PubMed Articles about Eureka Genomics Corp. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Eureka Genomics Corp. Companies in our database. You can also find out about relevant Eureka Genomics Corp. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record